drugset
drugset / Trial / NCT02611518

A Pharmacokinetic Interaction Study Between JNJ-54861911 and Transporter Substrates Rosuvastatin and Metformin in Healthy Participants

NCT02611518 ↗

Phase 1 Completed 32 enrolled Janssen Research & Development, LLC
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to look at how taking JNJ-54861911 every day will effect the amount of rosuvastatin or metformin in your blood after taking only a single dose of either one.

Timeline

Start
2016-04-05
Primary completion
2016-06-14
Completion
2016-06-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Atabecestat Small molecule 25 mg —
Subject Metformin Small molecule 500 mg Oral
Subject Rosuvastatin Small molecule 10 mg Oral

Indications

No indication recorded.